Are We Misreading Your Menopause or Missing Your ADHD?
As more midlife professional women, particularly Black and women of colour, report rising brain fog, anxiety and performance pressure at work, new research shows that many are only now recognising underlying ADHD during perimenopause. Studies confirm that perimenopause can intensify lifelong ADHD traits, leading to late diagnoses, especially among women historically overlooked or misdiagnosed.
This overlap matters. Peri menopausal cognitive changes (fog, overwhelm, memory lapses) can mimic or mask ADHD, making it harder for women and their clinicians to know what’s driving workplace challenges. Some reports show perimenopause reveals ADHD rather than causing it, highlighting how easily symptoms are misattributed in busy professional women.
At the same time, falling estrogen disrupts dopamine regulation, worsening inattention, executive dysfunction and emotional dysregulation, symptoms that heavily influence leadership, productivity and workplace wellbeing.
Yet not all data aligns. Newer research suggests ADHD does not always worsen menopausal symptoms, though higher ADHD trait severity does correlate with increased anxiety, mood disturbance and cognitive strain.
This contradiction raises essential questions about personalised care for diverse women.
Let’s not forget that for many, ADHD medications become less effective as hormones shift, a challenge worsened for Black and women of colour who already face limited access to integrated menopause and mental health support.
Below are 7 key discussion points every midlife professional woman, especially Black and women of colour, should consider when navigating the complex overlap between menopause and ADHD. At the end of each point it is followed by a practical recommendation to support your wellbeing at work and beyond.
1. Why Are So Many Women Getting ADHD Diagnoses For The First Time In Midlife?
Perimenopause can unmask and intensify lifelong neuro developmental symptoms that were previously masked, leading many high‑achieving women to seek assessment for the first time. Black and women of colour, already under diagnosed due to bias and cultural stigma, are particularly affected.
It is important for women to track symptoms (focus, memory, emotional shifts) over a 4–6 week period to present clearer patterns to clinicians, especially important where racial bias may delay diagnosis.
2. Brain Fog Is Not “Just Menopause” For Some, It Is A Diagnostic Turning Point.
Recent reporting shows peri menopausal brain fog, anxiety and overwhelm can uncover underlying ADHD rather than simply reflect hormonal change. This nuance is critical in workplace performance evaluations and wellbeing conversations.
If symptoms feel more like sudden executive dysfunction (missed deadlines, overwhelm, emotional swings), consider requesting a dual assessment: menopause + ADHD screening.
3. Women With ADHD Experience More Intense and Earlier Perimenopausal Symptoms.
Studies show they are almost twice as likely to experience severe psychological and physical symptoms, often years earlier than neuro typical peers, an issue magnified for women of colour who already face health inequities and delayed care. This includes anxiety, irritability and cognitive strain, often years earlier than peers.
If you can advocate for earlier workplace adjustments (flexible schedules, reduced cognitive load tasks during high‑symptom phases) rather than waiting until symptoms peak.
4. Estrogen Decline Directly Amplifies ADHD‑Related Cognitive and Emotional Challenges.
Fluctuating and falling estrogen disrupts dopamine regulation, worsening inattention, executive dysfunction, emotional reactivity and stress tolerance, key factors influencing workplace performance and leadership capacity.
Women in demanding leadership roles should consider scheduling high‑focus tasks during more stable phases of their cycle and building in recovery time around hormonally vulnerable periods.
5. Neurodivergent Women Face Greater Barriers In Accessing Menopause Care.
women of colour often navigate medical bias, communication barriers, dismissive car and past negative healthcare experiences reduce access to personalised support. When neuro divergence is added, these barriers compound, making culturally competent, neurodiversity‑affirming clinical practice essential.
Do not take this for granted. Bring a written summary of symptoms, questions and desired outcomes to clinical appointments to counteract dismissal and ensure concerns are documented.
6. Not All Studies Agree, Raising Questions Clinicians and Employers Must Pay Attention To.
Emerging research shows women with ADHD do not necessarily experience worse menopausal symptoms than others, but higher ADHD trait severity correlates strongly with increased menopausal complaints like anxiety, mood changes and cognitive strain. This complexity underscores the need for personalised assessments, not assumptions.
Going forward, clinicians and women should treat ADHD and menopause as overlapping, not competing conditions, to avoid misdiagnosis and inadequate care plans.
7. Medication May Become Less Effective During Menopause and Many Women Do Not Know Why.
Hormonal fluctuations can blunt ADHD medication and stimulant response, leaving accomplished women suddenly struggling at work, affecting workplace performance unexpectedly.
Collaborative care between psychiatrists and menopause specialists is now recognised as best practice, especially for women of colour who are less likely to receive integrated care.
If you feel you are not being heard, request a joint review with both a menopause specialist and ADHD clinician, especially critical for women of colour who receive less integrated care, to adjust dosage, timing, or consider HRT support.
As we bring these insights together, it is clear that the intersection of menopause and ADHD is not just a medical issue, it is a workplace wellbeing, leadership and equity issue. For many women, especially women of colour, these overlapping symptoms can quietly erode confidence, performance and mental health long before they receive appropriate clinical support.
By increasing awareness, advocating for culturally competent care and encouraging open dialogue in professional spaces, we can shift the narrative from silent struggle to informed self‑advocacy. Let this discussion be a catalyst for deeper understanding, better health conversations with clinicians and a more inclusive approach to supporting midlife women in every workplace and community.
If this conversation resonated with you, share lived experiences, not just symptoms ,so we can deepen understanding and shape better, culturally competent support frameworks.
Join the conversation:
Let's come together for a leadership conversation exploring menopause in the workplace and why women of colour are often overlooked in organisational wellbeing strategies here.
Are your workplace struggles hormonal, neurological, or both?
Have you noticed shifts in focus, memory, or emotional regulation during perimenopause?
How have cultural expectations or healthcare bias shaped your journey?
What support structures do you need to thrive at work during midlife?
